150 related articles for article (PubMed ID: 26386725)
1. EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression.
Zhang X; Jung IH; Hwang YS
Tumour Biol; 2016 Feb; 37(2):2555-63. PubMed ID: 26386725
[TBL] [Abstract][Full Text] [Related]
2. Functional invadopodia formation through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN expression.
Hwang YS; Xianglan Z; Park KK; Chung WY
Carcinogenesis; 2012 Nov; 33(11):2135-46. PubMed ID: 22859271
[TBL] [Abstract][Full Text] [Related]
3. Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition.
Chen R; Jin G; Li W; McIntyre TM
J Immunol; 2018 Oct; 201(7):2154-2164. PubMed ID: 30150285
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
[TBL] [Abstract][Full Text] [Related]
5. Stromal transforming growth factor-beta 1 is crucial for reinforcing the invasive potential of low invasive cancer.
Hwang YS; Park KK; Chung WY
Arch Oral Biol; 2014 Jul; 59(7):687-94. PubMed ID: 24769314
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin promotes cell migration via the EGF-Src-Cas pathway in oral squamous cell carcinoma cell lines.
Inoue H; Miyazaki Y; Kikuchi K; Yoshida N; Ide F; Ohmori Y; Tomomura A; Sakashita H; Kusama K
J Oral Sci; 2012 Sep; 54(3):241-50. PubMed ID: 23047035
[TBL] [Abstract][Full Text] [Related]
7. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
Lin MC; Huang MJ; Liu CH; Yang TL; Huang MC
Oral Oncol; 2014 May; 50(5):478-84. PubMed ID: 24582885
[TBL] [Abstract][Full Text] [Related]
8. CD206
Haque ASMR; Moriyama M; Kubota K; Ishiguro N; Sakamoto M; Chinju A; Mochizuki K; Sakamoto T; Kaneko N; Munemura R; Maehara T; Tanaka A; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S
Sci Rep; 2019 Oct; 9(1):14611. PubMed ID: 31601953
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis
Hsu JY; Chang JY; Chang KY; Chang WC; Chen BK
FASEB J; 2017 Oct; 31(10):4265-4276. PubMed ID: 28596235
[TBL] [Abstract][Full Text] [Related]
10. Role of insulin-like growth factor-II mRNA-binding protein-3 in invadopodia formation and the growth of oral squamous cell carcinoma in athymic nude mice.
Hwang YS; Park KK; Cha IH; Kim J; Chung WY
Head Neck; 2012 Sep; 34(9):1329-39. PubMed ID: 22052854
[TBL] [Abstract][Full Text] [Related]
11. Anti-EGFR antibody cetuximab is secreted by oral squamous cell carcinoma and alters EGF-driven mesenchymal transition.
Fujiwara T; Eguchi T; Sogawa C; Ono K; Murakami J; Ibaragi S; Asaumi JI; Okamoto K; Calderwood SK; Kozaki KI
Biochem Biophys Res Commun; 2018 Sep; 503(3):1267-1272. PubMed ID: 30017201
[TBL] [Abstract][Full Text] [Related]
12. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
[TBL] [Abstract][Full Text] [Related]
13. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
15. Lewis y Expressed in Oral Squamous Cell Carcinoma Attenuates Malignant Properties
Hotta H; Hamamura K; Shibuya H; Ohmi Y; Furukawa K; Furukawa K
Anticancer Res; 2021 Apr; 41(4):1821-1830. PubMed ID: 33813387
[TBL] [Abstract][Full Text] [Related]
16. Profile of epidermal growth factor receptor (EGFr) expression in human malignancies: effects of exposure to EGF and its biological influence on established human tumour cell lines.
Nouri AM; Thompson C; Cannell H; Symes M; Purkiss S; Amirghofran Z
Int J Mol Med; 2000 Oct; 6(4):495-500. PubMed ID: 10998445
[TBL] [Abstract][Full Text] [Related]
17. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation.
Chiang WF; Cheng TM; Chang CC; Pan SH; Changou CA; Chang TH; Lee KH; Wu SY; Chen YF; Chuang KH; Shieh DB; Chen YL; Tu CC; Tsui WL; Wu MH
Oncogene; 2018 Jan; 37(1):116-127. PubMed ID: 28892050
[TBL] [Abstract][Full Text] [Related]
19. Tumour progression in experimental oral carcinogenesis is associated with changes in EGF and TGF-beta receptor expression and altered responses to these growth factors.
Game SM; Stone A; Scully C; Prime SS
Carcinogenesis; 1990 Jun; 11(6):965-73. PubMed ID: 2161297
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of malignant oral rat keratinocytes reflects changes in EGF and TGF-beta receptor expression but not growth factor dependence.
Game SM; Stone A; Matthews JB; Scully C; Prime SS
Carcinogenesis; 1991 Mar; 12(3):409-16. PubMed ID: 1849051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]